News
WHO issues Draft Norms to Ensure High Quality of Drugs
The World Health Organization (WHO) has issued a draft of guidelines to ensure high drug quality standards in the market. Various recommendations, methodogical approaches have been provided in the draft. Comments are welcomed till 30th September 2015, and the topic will be presented in 50th WHO Expert Committee meeting held
DCGI Authorizes Zonal Officers to Grant Test Licenses
Zonal Officers gets authorization from the Drug Controller General of India (DCGI) to sign test licenses in Form 11 of the Drugs and Cosmetic Rules, 1945 which is used for importing small quantities of drugs for the purpose of conducting bioavailability/bioequivaience (BA/BE) study. On the subject, in the continuation of
NPPA says 2013 provisions are applicable to Notified Medical Devices
The clarification came from the National Pharmaceutical Pricing Authority (NPPA) that medical devices including orthopaedic implants will be in drugs category, which applies the provisions of DPCO 2013 to notified medical devices. NPPA said “Para 20 of DPCO, 2013 gives us the non-scheduled formulation monitoring. Under Drugs & Cosmetics Act
Fast Emerging Medical Devices Manufacturing and Import Hub in India
For medical and dental instruments UP is becoming an emerging manufacturing center. On the release of a study titled “Indian Medical Devices Industry: The way ahead” D.S. Rawat, national secretary general of Assocham said “By 2020, UP could emerge as manufacturing hub if tax concessions are made available for the
CDSCO to Change its Name?
The Indian drug regulator CDSCO (Central Drug Standard Control Organization) is all set to be revamped to a world class drug regulator. Inspired by the US FDA, India is making its drug regulator more efficient and of high quality. The CDSCO also might receive a new name “Central Drug Administration”
Rs. 500 Crore Venture Capital Fund for Pharma
The government of India plans to set up a venture capital fund worth 500 cr to boost the domestic pharma industry and also encourage establishing / upgrading domestic manufacturing facilities by providing loans cheaper. READ ALSO: The Indian Healthcare Market Overview. To make the medicines more affordable and rejuvenate the sector,
Just in Time Service by CDSCO
The Drugs Control General of India (DCGI), Dr G N Singh said “the just in time service basically ensures individual healthcare needs are not out of control due to the long regulatory processes with the lifesaving drugs/vaccines gets delayed. We have now started to give spot licenses to individuals under
Healthcare to drive growth : Cognizant
The revenue of Cognizant Technology Solutions Corp healthcare business surged about 43 per cent in the 1st quarter to $879.1 million which accounts for nearly a third of Cognizant’s total revenue. The company by acquiring TriZetto Corp, healthcare IT services provider, as expects its healthcare business to drive growth this year.
India and EU join hands for the Health Research
India and European Union will start researching on health focusing “Diagnostics and interventions in chronic non-communicable diseases” to develop and support the innovation between India and Europe. The research will focus on developing tools and techniques for diagnostics, interventions and mechanism in chronic non-communicable diseases. The project is funded through
Cyber Protect our Medical Devices
Harjinder Singh Lallie, principal teacher in Cyber Security at the University of Warwick said, “We don’t give the same significance that we give to money, to something that saves our lives”. Healthcare institutions comes in a second place after financial institutions as a target for the hackers around the world.